Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-Diagnostics, Inc.

Post-Mkt 05-21 19:52:26 EDT

3.71

+1.32

+55.23%

盘后3.50

-0.21-5.66%

19:52 EDT

High4.53	Low2.94	Vol91.50M
Open3.15	D1 Closing2.39	Amplitude66.52%
Mkt Cap13.37M	Tradable Cap12.59M	Total Shares3.60M
T/O336.45M	T/O Rate2,695.64%	Tradable Shares3.39M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-Diagnostics, Inc.","latestPrice":3.71,"timestamp":1779393600000,"preClose":2.39,"halted":0,"volume":91500013,"hourTrading":{"tag":"盘后","latestPrice":3.5001,"preClose":3.71,"latestTime":"19:52 EDT","volume":427056,"amount":1525748.949984,"timestamp":1779407539858,"change":-0.2099,"changeRate":-0.056577,"amplitude":0.070081},"delay":0,"changeRate":0.5523012552301254,"floatShares":3394376,"shares":3602500,"eps":-29.3895,"marketStatus":"Post-Mkt","change":1.32,"latestTime":"05-21 19:52:26 EDT","open":3.15,"high":4.5299,"low":2.94,"amount":336452227.301949,"amplitude":0.66523,"askPrice":3.52,"askSize":6865,"bidPrice":3.5,"bidSize":2055,"shortable":3,"etf":0,"ttmEps":-29.3895,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1779408000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":3.1889,"preClose":2.39,"latestTime":"09:29 EDT","volume":6961283,"amount":21339994.029858,"timestamp":1779370199960,"change":0.7989,"changeRate":0.334268,"amplitude":0.502092},"postHourTrading":{"tag":"盘后","latestPrice":3.5001,"preClose":3.71,"latestTime":"19:52 EDT","volume":427056,"amount":1525748.949984,"timestamp":1779407539858,"change":-0.2099,"changeRate":-0.056577,"amplitude":0.070081},"volumeRatio":3.368733,"impliedVol":1.6193,"impliedVolPercentile":0.4808},"requestUrl":"/m/hq/s/CODX","defaultTab":"news","newsList":[{"id":"2637038042","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637038042","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637038042?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:08","pubTimestamp":1779361719,"startTime":"0","endTime":"0","summary":"Wheeler Real Estate Investment Trust  shares were up 80% in Thursday premarket activity following a nearly 2% fall in the previous session.Liminatus Pharma  stock was 50% higher after the company agreed to merge with InnocsAI.Agape ATP  shares were up 43% after a 3.2% loss in the previous session.Co-Diagnostics  stock was 36% higher after the company announced a $3 million private placement, extending Wednesday's 21% rally.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","CODX","BK4082","LIMN","BK4139","BK4568","WHLR","ATPC","BK4231","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636946778","title":"Co-Diagnostics prices USD 3 million private placement at market under Nasdaq rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2636946778","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636946778?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:55","pubTimestamp":1779245718,"startTime":"0","endTime":"0","summary":"Co-Diagnostics entered a $3 million at-the-market private placement with institutional investors, selling 1,647,447 common shares or pre-funded warrants.The deal includes warrants to buy up to 3,294,894 common shares, priced with a combined effective offering price of $1.82 per share and warrants.The warrants carry a $1.57 exercise price, are exercisable immediately, and expire five years from issuance.Closing is expected around May 21, 2026, subject to customary conditions.The securities were sold in an unregistered private placement under Section 4 and/or Regulation D.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL2H5SqY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636894672","title":"Co-Diagnostics Announces $3.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2636894672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636894672?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:55","pubTimestamp":1779245701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA79NGDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636586868","title":"BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2636586868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636586868?lang=en_us&edition=fundamental","pubTime":"2026-05-19 23:48","pubTimestamp":1779205729,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy  Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL6N41W134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALB","CRMG","HSBA.UK","CODX","AS","WOK","DRVN","WDAY","GOOX","NVDS.UK","XE","GGLL","BX","INM","ONCO","WNW","HIMZ","YMAT","HIMS","GOU","CRM","NVDW","NVD2.UK","AMST","HOTH","NOW","HIYY","NVD3.UK","HD","INTU","GOOW","SKLZ","SITM","BDX","CTRE","2NVD.UK","DIPS","HMYY","VRT","CVNA","NVDA","HIMY","RLAY","KR","ONTO","VPG","GOOGL","GOOY","TE","NVDQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636851464","title":"Co-Diagnostics develops ebola assay strategy after recent global outbreak alert","url":"https://stock-news.laohu8.com/highlight/detail?id=2636851464","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636851464?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:16","pubTimestamp":1779196573,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) has completed the assay development strategy for the Bundibugyo virus currently causing an outbreak of Ebola disease in the D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-develops-ebola-assay-strategy-after-recent-global-outbreak-alert-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-develops-ebola-assay-strategy-after-recent-global-outbreak-alert-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636851801","title":"Co-Diagnostics plans rapid rollout of Bundibugyo Ebola PCR test if needed","url":"https://stock-news.laohu8.com/highlight/detail?id=2636851801","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636851801?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:05","pubTimestamp":1779195914,"startTime":"0","endTime":"0","summary":"Co-Diagnostics completed a development strategy to support a future PCR assay for Bundibugyo virus, positioning the company to rapidly make a test available if demand emerges from the current Ebola outbreak in the Democratic Republic of the Congo and Uganda.Planned execution centers on deploying the assay through its cloud-connected, decentralized point-of-care PCR platform to improve real-time outbreak visibility for public health response.Management signaled an intent to collaborate with government and non-government organizations on further development as needed, targeting faster detection to support containment efforts.The move comes as the WHO declared the outbreak a public health emergency of international concern on May 17, with eight laboratory-confirmed cases and 246 suspected cases reported in the Democratic Republic of the Congo, plus two laboratory-confirmed cases in Uganda.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL6cywWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636859799","title":"Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert","url":"https://stock-news.laohu8.com/highlight/detail?id=2636859799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636859799?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:01","pubTimestamp":1779195675,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W070:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635649720","title":"Co-Diagnostics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635649720","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635649720?lang=en_us&edition=fundamental","pubTime":"2026-05-15 08:33","pubTimestamp":1778805189,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc reports results for the quarter ended March 31 - Earnings SummaryCo-Diagnostics Inc CODX.OQ reported a quarterly adjusted loss of $4.06 per share for the quarter ended March 31, hig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S012:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725373","title":"Co-Diagnostics Q1 FY26 net loss widens to $9.1 million; revenue holds at $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725373","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725373?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:18","pubTimestamp":1778789883,"startTime":"0","endTime":"0","summary":"Co-Diagnostics posted a net loss of USD 9.1 million for the three months ended March 31, 2026, widening from a loss of USD 7.5 million a year earlier.Revenue was USD 0.1 million, while cost of revenues rose to about USD 0.2 million from roughly USD 22,000.Operating expenses increased to USD 9.2 million from USD 8.6 million, driven by clinical trial spending for Co-Dx PCR platform and higher legal and professional services costs.Cash and cash equivalents totaled USD 8.2 million at March 31, 2026, while net cash used in operating activities was USD 7.8 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analys","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL4m8dXt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635272340","title":"Co-Diagnostics Q1 revenue rises but net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2635272340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635272340?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:10","pubTimestamp":1778789444,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Q1 revenue rises but net loss widensOverviewUS molecular diagnostics firm's Q1 revenue rose yr/yr, but net loss widenedHigher operating expenses driven by R&D spending increased operati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R18L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723375","title":"Co-Diagnostics Q1 EPS $(4.06) Misses $(3.90) Estimate, Sales $145.954K Miss $163.500K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723375","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723375?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:03","pubTimestamp":1778789036,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Q1 EPS $(4.06) Misses $(3.90) Estimate, Sales $145.954K Miss $163.500K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/CODX","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Co-Diagnostics Q1 EPS $(4.06) Misses $(3.90) Estimate, Sales $145.954K Miss $163.500K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728293","title":"Co-Diagnostics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728293?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:01","pubTimestamp":1778788861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA1X9MH4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728247","title":"Co-Diagnostics Q1 Revenue USD 150 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728247?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:01","pubTimestamp":1778788860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLXF862D2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635280842","title":"Co-Diagnostics files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2635280842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635280842?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:55","pubTimestamp":1778619331,"startTime":"0","endTime":"0","summary":"16:33 EDT Co-Diagnostics (CODX) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635525228","title":"Co-Diagnostics Inc  expected to post a loss of $3.75 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2635525228","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635525228?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:39","pubTimestamp":1778618345,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc  expected to post a loss of $3.75 a share - Earnings Preview Co-Diagnostics Inc CODX.OQ CODX.O is expected to  show a rise in quarterly revenue when it reports  results on May 14 fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P34B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635124007","title":"BRIEF-Co-Diagnostics Inc - May Offer And Sell Up To $150 Million In Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635124007","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635124007?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:33","pubTimestamp":1778618028,"startTime":"0","endTime":"0","summary":"BRIEF-Co-Diagnostics Inc - May Offer And Sell Up To $150 Million In Securities - SEC FilingMay 12  - Co-Diagnostics Inc CODX.O:CO-DIAGNOSTICS INC - MAY OFFER AND SELL UP TO $150 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001493152-26-022504]Further company coverage: CODX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635201240","title":"Co-Diagnostics Inc - May Offer and Sell up to $150 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635201240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635201240?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:31","pubTimestamp":1778617916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468929","title":"Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468929","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468929?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:28","pubTimestamp":1778254091,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) announced that its joint venture, CoMira Diagnostics, has finalized a lease agreement for its planned manufacturing facility ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-joint-venture-with-comira-finalizes-facility-lease-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-joint-venture-with-comira-finalizes-facility-lease-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633451315","title":"Co-Diagnostics joint venture CoMira signs lease for Saudi manufacturing facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2633451315","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633451315?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:03","pubTimestamp":1778245404,"startTime":"0","endTime":"0","summary":"Co-Diagnostics joint venture CoMira signed lease for planned manufacturing facility in Sudair Industrial City, Saudi Arabia.Lease covers about 14,400 square feet; site slated for manufacturing diagnostic instruments, lab equipment, medical consumables.Move shifts project from planning to buildout, supporting localized production strategy tied to Saudi Arabia Vision 2030.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on May 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL90b0Zr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633776459","title":"Co-Diagnostics Joint Venture Comira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City","url":"https://stock-news.laohu8.com/highlight/detail?id=2633776459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633776459?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUACFF1H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":0.4938},{"period":"1month","weight":0.4311},{"period":"3month","weight":-0.0229},{"period":"6month","weight":-0.7725},{"period":"1year","weight":-0.7103},{"period":"ytd","weight":-0.5275}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.280232},{"month":2,"riseRate":0.222222,"avgChangeRate":0.209425},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.179204},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.011372},{"month":5,"riseRate":0.444444,"avgChangeRate":0.101581},{"month":6,"riseRate":1,"avgChangeRate":0.106921},{"month":7,"riseRate":0.625,"avgChangeRate":0.172835},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.06719},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003584},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.082815},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.196965}],"exchange":"NASDAQ","name":"Co-Diagnostics, Inc.","nameEN":"Co-Diagnostics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-Diagnostics, Inc.,CODX,Co-Diagnostics, Inc.股票,Co-Diagnostics, Inc.股票老虎,Co-Diagnostics, Inc.股票老虎国际,Co-Diagnostics, Inc.行情,Co-Diagnostics, Inc.股票行情,Co-Diagnostics, Inc.股价,Co-Diagnostics, Inc.股市,Co-Diagnostics, Inc.股票价格,Co-Diagnostics, Inc.股票交易,Co-Diagnostics, Inc.股票购买,Co-Diagnostics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}